These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14975573)

  • 1. Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score.
    Vermeulen EG; van Engeland MI; Visser FC; Stehouwer CD; Twisk JW; van Campen CM; Rauwerda JA
    Int J Cardiol; 2004 Feb; 93(2-3):323-4. PubMed ID: 14975573
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
    Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
    Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
    van Guldener C
    Nephrol Dial Transplant; 2006 May; 21(5):1161-6. PubMed ID: 16490741
    [No Abstract]   [Full Text] [Related]  

  • 5. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
    Alvares Delfino VD; de Andrade Vianna AC; Mocelin AJ; Barbosa DS; Mise RA; Matsuo T
    Nutrition; 2007 Mar; 23(3):242-7. PubMed ID: 17321110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
    Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
    Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.
    Levine J; Stahl Z; Sela BA; Ruderman V; Shumaico O; Babushkin I; Osher Y; Bersudsky Y; Belmaker RH
    Biol Psychiatry; 2006 Aug; 60(3):265-9. PubMed ID: 16412989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.
    van Vliet T; Jacobs RG; de Deckere E; van den Berg H; de Bree A; van der Put NM
    Eur J Clin Nutr; 2007 Jun; 61(6):769-78. PubMed ID: 17151589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
    Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
    Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.
    Dinckal MH; Aksoy N; Aksoy M; Davutoglu V; Soydinc S; Kirilmaz A; Dinckal N; Akdemir I
    Acta Cardiol; 2003 Oct; 58(5):389-96. PubMed ID: 14609303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
    Mann JF; Sheridan P; McQueen MJ; Held C; Arnold JM; Fodor G; Yusuf S; Lonn EM;
    Nephrol Dial Transplant; 2008 Feb; 23(2):645-53. PubMed ID: 18003666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine lowering and cognitive performance.
    Dettling M; Opgen-Rhein C; Anghelescu IG
    N Engl J Med; 2006 Sep; 355(13):1390; author reply 1391. PubMed ID: 17014040
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing coronary artery disease by decreasing homocysteine levels.
    Coffey M; Crowder GK; Cheek DJ
    Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
    [No Abstract]   [Full Text] [Related]  

  • 20. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
    House AA; Eliasziw M; Urquhart BL; Freeman DJ; Spence JD
    Am J Kidney Dis; 2004 Oct; 44(4):689-94. PubMed ID: 15384020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.